Synthesis, Structure, and Biological Activity of Mixed-Ligand Amine-Containing Copper(II) Coordination Compounds with 2-(2-Hydroxybenzylidene)-N-(prop-2-en-1-yl)hydrazinecarbothioamide

Gulya Aurelian; Graur Vasilii О.; Ulchina Ianina; Bourosh Pavlina; Smaglii Vadim; Garbuz Olga; Tsapkov Victor I.

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

712

SM ISO690:2012

GULYA, Aurelian, GRAUR, Vasilii О., ULCHINA, Ianina, BOUROSH, Pavlina, SMAGLII, Vadim, GARBUZ, Olga, TSAPKOV, Victor I.. Synthesis, Structure, and Biological Activity of Mixed-Ligand Amine-Containing Copper(II) Coordination Compounds with 2-(2-Hydroxybenzylidene)-N-(prop-2-en-1-yl)hydrazinecarbothioamide. In: Russian Journal of General Chemistry, 2021, vol. 91, pp. 98-107. ISSN 1070-3632. DOI: https://doi.org/10.1134/S1070363221010114

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Russian Journal of General Chemistry

Volumul 91 / 2021 / ISSN 1070-3632 /ISSNe 1608-3350

Synthesis, Structure, and Biological Activity of Mixed-Ligand Amine-Containing Copper(II) Coordination Compounds with 2-(2-Hydroxybenzylidene)-N-(prop-2-en-1-yl)hydrazinecarbothioamide

DOI:https://doi.org/10.1134/S1070363221010114

Pag. 98-107

Gulya Aurelian¹, Graur Vasilii О.¹, Ulchina Ianina¹, Bourosh Pavlina², Smaglii Vadim³, Garbuz Olga¹⁴, Tsapkov Victor I.¹

¹ Moldova State University,
² Institute of Applied Physics,
³ Institute of Chemistry,
⁴ Institute of Zoology

Proiecte:

20.80009.8007.03 Noi substanțe cu potențial preventiv și terapeutic în baza compușilor naturali de origine vegetală și a matodelor moderne de sinteză organică

Disponibil în IBN: 6 aprilie 2021

Rezumat

Abstract: Сopper(II) nitrate reacts in ethanol with 2-(2-hydroxybenzylidene)-N-(prop-2-en-1-yl)hydrazinecarbothioamide H₂L in an 1 : 1 molar ratio to form the coordination compound Cu(HL)NO₃·H₂O. The introduction of amines [imidazole (Im), 3,5-dibromopyridine (3,5-Br₂Py), and 4-methylpyridine (4-Pic)] into the reaction mixture in a molar ratio 1 : 1 : 2 leads to the formation of CuA(HL)NO₃·nH₂O [A = Im, 3,5-Br₂Py, 4-Pic; n = 0, 3] complexes. The structure of the obtained compounds was determined by X-ray structural analysis. The synthesized complexes exhibit antimicrobial, antifungal, antioxidant, and anticancer activities.

Cuvinte-cheie
Amines, anticancer activity, Antimicrobial activity, Cu(II) coordination compounds, salicylaldehyde 4-allylthiosemicarbazone

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-126712</cfResPublId>
<cfResPublDate>2021-01-13</cfResPublDate>
<cfStartPage>98</cfStartPage>
<cfISSN>1070-3632</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/126712</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>Synthesis, Structure, and Biological Activity of Mixed-Ligand Amine-Containing Copper(II) Coordination Compounds with 2-(2-Hydroxybenzylidene)-N-(prop-2-en-1-yl)hydrazinecarbothioamide</cfTitle>
<cfKeyw cfLangCode='EN' cfTrans='o'>Amines; anticancer activity; Antimicrobial activity; Cu(II) coordination compounds; salicylaldehyde 4-allylthiosemicarbazone</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Abstract: Сopper(II) nitrate reacts in ethanol with 2-(2-hydroxybenzylidene)-N-(prop-2-en-1-yl)hydrazinecarbothioamide H<sub>2</sub>L in an 1 : 1 molar ratio to form the coordination compound Cu(HL)NO<sub>3</sub>&middot;H<sub>2</sub>O. The introduction of amines [imidazole (Im), 3,5-dibromopyridine (3,5-Br<sub>2</sub>Py), and 4-methylpyridine (4-Pic)] into the reaction mixture in a molar ratio 1 : 1 : 2 leads to the formation of CuA(HL)NO<sub>3</sub>&middot;nH<sub>2</sub>O [A = Im, 3,5-Br<sub>2</sub>Py, 4-Pic; n = 0, 3] complexes. The structure of the obtained compounds was determined by X-ray structural analysis. The synthesized complexes exhibit antimicrobial, antifungal, antioxidant, and anticancer activities.&nbsp;</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-499</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-25988</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-69135</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-197</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-46712</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-42831</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-12188</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfFedId>
<cfFedIdId>ibn-doi-126712</cfFedIdId>
<cfFedId>10.1134/S1070363221010114</cfFedId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
<cfFedId_Class>
<cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId>
<cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId>
</cfFedId_Class>
<cfFedId_Srv>
<cfSrvId>5123451</cfSrvId>
<cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId>
</cfFedId_Srv>
</cfFedId>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-499</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-499-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
<cfFamilyNames>Gulya</cfFamilyNames>
<cfFirstNames>Aurelian</cfFirstNames>
<cfFamilyNames>Гуля</cfFamilyNames>
<cfFirstNames>Аурелиан</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-25988</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-25988-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
<cfFamilyNames>Graur</cfFamilyNames>
<cfFirstNames>Vasilii О.</cfFirstNames>
<cfFamilyNames>Граур</cfFamilyNames>
<cfFirstNames>Василий</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-69135</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-69135-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
<cfFamilyNames>Ulchina</cfFamilyNames>
<cfFirstNames>Ianina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-197</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-197-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
<cfFamilyNames>Bourosh</cfFamilyNames>
<cfFirstNames>Pavlina</cfFirstNames>
<cfFamilyNames>Боурош</cfFamilyNames>
<cfFirstNames>Павлина</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-46712</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-46712-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
<cfFamilyNames>Smaglii</cfFamilyNames>
<cfFirstNames>Vadim</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-42831</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-42831-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
<cfFamilyNames>Garbuz</cfFamilyNames>
<cfFirstNames>Olga</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-12188</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12188-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-01-13T24:00:00</cfStartDate>
<cfFamilyNames>Tsapkov</cfFamilyNames>
<cfFirstNames>Victor I.</cfFirstNames>
<cfFamilyNames>Цапков</cfFamilyNames>
<cfFirstNames>Виктор</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfSrv>
<cfSrvId>5123451</cfSrvId>
<cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName>
<cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr>
<cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw>
</cfSrv>
</CERIF>